CD274 and neoplasm: Nevertheless, according to the literature, tumor mutation burden levels do not differ in tumors depending on the number of TILs and PD-L1 expression, although trends of higher tumor mutation burden levels in tumors with more TILs and in tumors without PD-L1 expression have been described [12].